| Healthy | Patient |
---|
 |
A
1
|
A
2
|
G
1
|
G
2
|
A
1
|
A
2
|
G
1
|
G
2
|
TR
| 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
V
| 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
TE
| 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
- All 140 patients and 140 healthy subjects were divided into a training set (TR), a validation set (V) and a test set (TE). Each set satisfied two criteria: balance between patients and healthy subjects, and even distribution on gender and age.